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ABSTRACTS
Oral administration of the ethanol extract of Caesalpinia pulcherrima 
seeds (CP - 250 and 500 mg/kg) caused significant fall in blood glucose 
levels even at 2½ h after a single dose of treatment in normal fasted 
and glucose loaded Wistar albino rats. At 250 mg/kg dose level, CP 
completely prevented the elevation of blood glucose caused by oral 
glucose feeding. In alloxan diabetic rats, CP was able to lower the blood 
glucose level to around 132 mg / 100 ml from 10th day and thereafter. 
The biochemical findings were supported by histopathological studies 
of liver, kidney and pancreas of control and treated rats. CP was able 
to increase catalase levels of diabetic rats. Reduced levels of serum 
protein and elevated levels of Aspartate aminotransferase (AST), 
Alanine transaminase (ALT), alkaline phosphatase(ALP), cholesterol, 
triglycerides, creatinine and uric acid were almost normalised in 
CP treated diabetic rats. CP was also able to reduce in vitro lipid 
peroxidation in rat liver microsomes and inhibit 1- diphenyl – 2-picryl 
hydrazyl (DPPH) induced free radicals significantly.
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INTRODUCTION
Medicinal plants are Nature’s gift to mankind and 
they form part of the rich heritage of India. Plant 
drugs are considered to be less toxic and free from side 
effects than synthetic ones.1 Many Indian medicinal 
plants have been found to be useful in successfully 
managing diabetes and from some of them, active 
principles have been isolated.2 It is well known 
that herbal plants like Garlic (Allium sativum), 
Tulsi (Ocimum sanctum), Neem (Azadirachta 
indica) and Bitter gourd (Momordica charantia) 
not only possess hypoglycaemic activity but some 
of them are hypotensive, hepatoprotective and also 
blood purifiers.1 Caesalpinia pulcherrima (L.) Sw. 
belonging to the family Caesalpinaceae is known as 
‘Peacock Flower’ or ‘Red Bird of Paradise’ in English 
and ‘Rajamalli’ in Malayalam. It is an exotic, hardy 
shrub or small tree, growing up to 5  m in height 
and cultivated in gardens throughout India. The 
seeds of C pulcherrima is used in traditional medi-
cine of Kerala to treat diabetes. The roots are used 
as a remedy for lung and skin diseases. They are 
prescribed as a decoction for intermittent fevers 
and in the powdered form for infantile convulsions. 
The dried and powdered leaves are used to treat in 
erysipelas. The bark is higly astringent and widely 
used as an emmenogogue. The flowers are a remedy 
for intestinal worms. The anti - diabetic effects of 
C pulcherima have not scientifically validated yet. In 
the present study, the effect of Caesalpinia pulcher-
rima seeds on metabolic parameters of normal and 
alloxan – induced diabetic rats is reported. 
MATERIALS AND METHODS
Plant material and preparation of the 
extract 
The seeds of Caesalpinia pulcherrima were 
collected from Palode, Thiruvananthapuram 
District, Kerala. They were authenticated by the 
plant taxonomist of the Institute and a voucher 
specimen (TBGT 57024 dated 17/ 04 / 07) was 
deposited at the Institute’s Herbarium. The seeds 
were shade dried and powdered. The powder 
(100 gm) was successively extracted with 1000 ml 
of ethanol overnight, at room temperature with 
constant stirring. The extract was filtered and the 
filtrate concentrated under reduced pressure to 
yield 750 mg of the crude extract (0.75 % with 
respect to the dried plant material). This crude 
extract was referred to as CP. It was reconstituted 
in 0.25% Tween-80, to desired concentrations and 
used for the experiments.
Animals
Wistar albino rats, males (250 - 300g) and Swiss 
albino mice, males (25 – 30 g), were obtained from 
the Institute’s Animal House. They were housed 
under standard laboratory conditions  (temperature 
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24 - 28°C, relative humidity 60 – 70 % and 12  h 
dark and light cycles) and fed commercial rat feed 
(Lipton India Ltd., Mumbai, India) and boiled 
water, ad libitum. All experiments involving animals 
were carried out according to NIH guidelines, after 
getting the approval of the Institute’s Animal Ethics 
Committee.
Effect of crude extract (CP) on glucose 
tolerance
Rats were divided into 4 groups, of six animals 
and fasted overnight. Group I, the vehicle control 
received 1ml of 0.25 % Tween - 80.Groups II and 
III were given po, the crude extract, CP (250 and 
500  mg/kg). Glibenclamide (600 mg /kg) in 
10%Tween - 80 was given to the positive control to 
group IV. Rats of all the groups were loaded with 
60 % glucose (3 g /kg, po), 30 min. after CP admin-
istration. Blood samples were collected from the 
orbital plexus4 just prior to drug administration and 
at 30 min, 90 and 150 min after glucose loading and 
glucose levels were determined spectroscopically.
Hypoglycaemic study in normal fasted rats 
with CP 
Overnight fasted rats were divided into 4 groups of 
6 rats each. Group I received 1ml of 0.25% Tween - 
80 (control) and groups II and III received orally CP 
at 250 mg/kg and 500 mg/kg doses. Blood samples 
were collected from the orbital plexus at 60 and 
120 min. after CP administration and glucose levels 
were measured spectroscopically. Glibenclamide 
(600 mg/kg) was administered to Group IV animals 
(positive control). 
Effect of CP on alloxan induced diabetic rats 
Rats were made diabetic by injecting alloxan 
(60 mg / kg)5 through tail vein. 5 days later, blood 
samples were drawn and glucose levels were deter-
mined and the diabetic rats exhibiting glucose 
levels in the range of 400 – 450 mg /100 ml were 
selected for further studies.
Of the 5 experimental groups, Group I comprised 
of 6 normal non diabetic control animals and were 
given a single daily dose of 0.25 % Tween - 80 
(1  ml, po), Alloxan induced diabetic rats were 
divided into 4 groups of 6 rats each (Groups II - V). 
Group II (alloxan diabetic control) received a single 
daily dose of 0.25% Tween - 80 (1ml, po), Groups 
III and IV were administered a single daily dose 
of CP (250 and 500 mg / kg, po respectively) and 
GroupV animals received po, 600 mg / kg of the 
standard drug, glibenclamide. The treatments were 
continued for 15 days. Blood samples were collected 
in the morning, 1 h after CP administration on day 
1, 4, 7, 10 and 15. 
Biochemical and histological studies
On day 15th, animals were sacrificed by mild ether 
anesthesia and blood was collected from all the five 
groups, for biochemical studies and liver, pancreas 
and kidney samples were collected for histological 
studies.
Biochemical parameters like Alanine transam-
inase (ALT), Aspartate aminotransferase (AST), 
serum alkaline phosphatase (ALP), cholesterol, 
total protein, creatinine, uric acid and triglycerides 
were assayed according to standard methods.6-12 
Seven µm thick paraffin sections of buffered forma-
lin - fixed liver, pancreas and kidney samples were 
stained with haematoxylin - eosin for photomicro-
scopic observations of the organ histological archi-
tecture, of the control and treated rats.
Antilipid peroxidation studies
The antilipid peroxidant effect of CP was studied 
in vitro, following modified methods.13,14 Briefly, 
0.5 gm of the rat liver tissue was homogenized with 
10 ml of 150 mM KCl-Tris-HCl buffer (pH 7.2). 
0.25 ml of liver homogenate, Tris - HCl buffer 
(pH 7.2), 0.05 ml of 0.1 mM ascorbic acid (AA), 
0.05  ml of 4 mM FeCl2 and 0.05 ml of varying 
concentrations of CP extract. The mixture (in tripli-
cate) was incubated at 37°C for 1 hr in capped tubes. 
Then 0.5 ml of 0.1 N HCl, 0.02 ml of 9.8% sodium 
dodecyl sulphate (SDS), 0.9 ml of distilled water and 
2 ml of 0.6% thiobarbituric acid (TBA) was added 
to each tube and vigorously shaken. All the tubes 
were then placed in a boiling water bath at 100°C 
for 30 min. After cooling the flocculent precipitate 
was removed by adding 5 ml of n - butanol and they 
were centrifuged at 3000 rpm for 20 min. The absor-
bance of the supernatant was measured at 532 nm.
DPPH radical scavenging activity 
DPPH radical scavenging activity was measured by 
the spectrophotometric method.15 To an ethanol 
solution of DPPH (200 µM), 0.05 ml of CP dissolved 
in ethanol were added at different concentrations 
(100 - 500 µg/ ml). An equal amount of ethanol was 
added to the control. After 20 min, the decrease 
in the absorbance of the test mixture (CP) (due 
to quenching of DPPH free radicals) was read at 
517 nm and the percentage inhibition calculated by 
using the formula16 given below.
Behavioural and toxic effects
four groups of 12 mice were administered p.o. 250, 
500, 1000 and 1500 mg/kg of the CP extract. They 
were observed continuously for 1 h for any gross 
behavioral changes, symptoms of toxicity and 
mortality if any and intermittently for the next 6 h 
and then again, 24 h after dosing with CP extract.
Effect of Caesalpinia pulcherrima  ... R. Babujanarthanam et al.
www.diabesity.ejournals.ca Diabesity 2018; 4(3): 9-16. doi: 10.15562/diabesity.2018.49 11
Statistical analysis 
Data were expressed as mean ± standard deviation 
of the mean (SD), and statistical comparisons were 
performed using Student’s‘t’ test.17
RESULTS
Effect of CP on blood glucose levels of 
normal fasted and glucose loaded rats 
Oral administration of CP at 250 mg/kg showed 
significant fall in blood glucose level, 2 ½ hours 
after a single dose of treatment in normal fasted and 
glucose loaded rats. CP was effective at 250 mg/kg 
dose in depressing the value of blood glucose at 
30 min. after glucose loading (Table 1).
Effect of CP on blood glucose levels of 
hypoglycaemic rats 
CP showed significant hypoglycaemic activity at 
250 mg/kg dose and decreased the blood glucose 
level significantly up to 120 min after administra-
tion (Table 2).
Effect of CP on blood glucose levels of 
alloxan - diabetic rats
The blood glucose levels of alloxan - diabetic rats 
was in the range of 298 – 412 mg/ 100ml. In the CP 
treated group, blood glucose level steadily decreased 
and it was around 132 mg/ 100 ml on the 10th day. 
On the 15th day, blood glucose level decreased to 
around 120 mg/100ml. (Table 3). 
Effect of CP on other serum biochemical 
parameters of alloxan diabetic rats 
A significant increase in the Alanine transami-
nase (ALT), Aspartate aminotransferase (AST) 
and alkaline phosphatase (ALP) activities were 
recorded in diabetic rats compared to normal 
rats, indicating an altered liver function in the 
diabetic condition. But a significant reduction in 
the values of ALT, AST and ALP were collectively 
indicates that the restorations of its activities were 
found in both CP treated groups compared to 
diabetic rats. ALT level in group which is treated 
with CP 500mg/kg was found to be 57.31 ± 6.09 
which is closer to normal control 83.31 ± 6.12 
than the animals treated with CP 250mg/kg their 
level was 52.32 ± 6.12. AST levels were found to 
be more or less same in all CP and Glibenclamide 
treated groups and but significantly reduced when 
compared with diabetic control group. The results 
of Group 3, treated with CP 250mg/kg showed that 
the ALP level was near normal as in the cases of 
normal control and Glibenclamide treated group 
as well. Serum levels of total cholesterol, triglycer-
ide, creatinine and uric acid levels were found to be 
significantly increased with lowered total protein 
concentration in the diabetic group. Upon treated 
with two different dosage levels of CP 250mg/kg 
and 500mg/kg, the results showed that significant 
normalization of these elevated serum parameter 
levels with increased total protein concentration 
when compared with diabetic control. The results 
have clearly indicates that the restoration to near 
normal levels of total cholesterol (50.71±6.09), 
creatinine (0.59±0.10) and uric acid levels 
(0.67±0.12) were found in CP with dosage level 
of 250mg/kg treated group. Meanwhile, all other 
serum biochemical parameters were also found 
to be more or less at near normal invariably in 
all the drug treated alloxan induced diabetic rats.
(Tables 4 and 5).
Effect of CP on hepatic catalase, glycogen 
and protein levels 
Administration of CP at 250 and 500 mg/kg dose 
raised the activity of CAT in liver tissue of diabetic 
animals. There was a significant increase in the 
values of liver glycogen and liver protein in the 
CP and standard antidiabetic drug glibenclamide 
treated groups (Table 6).
Histopathology
Histopathological observations basically supported 
the serum parameter assays. Pancreatic sections 
of diabetic rats showed atrophy of β – cells and 
vascular degenerative changes in islets. CP and 
standard antidiabetic drug glibenclamide treated 
groups treated pancreas showed increase in the 
islets. Liver tissue of the diabetic rats showed 
distortion in the arrangement of cells around the 
central vein and fibrosis. CP treatment restored 
the cellular arrangement and reduced fibrosis. 
Kidney sections of diabetic animals showed wall 
thickening of nephrons and glomerulopathy. 
CP treatmet reversed these changes significantly 
(Figures 1 – 3, a - d).
Effect of CP on in vitro lipid peroxidation 
CP showed very potent inhibition of FeCl2 - AA 
stimulated rat liver lipid peroxidation in vitro at 
concentrations of 1-10 μg /ml. There was a signif-
icant increase of malondialdehyde (MDA) in 
FeCl2-AA treated rat liver homogenate, compared 
to normal control without FeCl2 - AA (Table 7).
Effect of CP on DPPH free radical 
scavenging activity 
CP showed maximum inhibition (75.37 %) of 
DPPH free radical at 400 µg /ml. 25 µg /ml dose 
failed to evoke significant response and it was 
observed that the free radical was scavenged in a 
concentration dependent manner upto 400 µg /ml. 
(Table 8).
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Table 1  Effect of ethanol extract of Caesalpinia pulcherrima seeds (CP) on blood glucose levels of normal fasted and 
glucose loaded rats. [Values are mean ± SD of 6 animals]
Groups
Blood glucose (mg/100 ml)
0 min 30 min 90 min 150 min
Normal control (0.25 % Tween – 80) 56.0 ± 5.0 141.0 ± 3.2 133.0 ± 4.2 115.0 ± 1.2
CP(250 mg/kg) 58.9 ± 1.4 82.3 ± 1.7** 86.3 ± 1.6** 81.4 ± 2.1**
CP(500 mg/kg) 53.6±1.2 108.3 ± 1.2** 109.3 ± 1.6** 106.3 ± 1.2**
Glibenclamide (600 mg/kg) 60.1±1.75 58.1 ± 1.3** 40.0 ± 1.2** 40.0 ± 1.3**
** Significance P ≤ 0.01, compared to normal control group
Table 2  Effect of ethanol extract of Caesalpinia pulcherrima (CP) on blood glucose levels of hypoglycaemic rats. 
[Values are mean ± SD of 6 animals]
Groups
Blood glucose (mg/100 ml)
0 min 60 min 120 min
Normal control (0.25 % Tween – 80) 67.4 ± 1.8 63.2 ± 1.7 63.4 ± 1.3
CP(250 mg/kg) 66.3 ± 1.6 46.0 ± 0.8** 51.8 ± 0.9**
CP(500 mg/kg) 63.2 ± 1.6 49.3 ± 0.7 54.3 ± 1.0**
Glibenclamide (600mg/kg) 65.1 ± 1.3 58.1 ± 1.3** 60.0 ± 1.3**
** Significance P ≤ 0.01, compared to normal control group
Table 4  Effect of ethanol extract of Caesalpinia pulcherrima (CP) on other serum biochemical parameters of alloxan 
diabetic rats. [Values are mean ± SD of 6 animals]
Groups ALT (IU/L) AST (IU/ L) ALP (IU/L)
Normal Control (0.25% Tween 80) 83.31 ± 6.12 123.21 ± 6.23 207.31 ± 9.01
Alloxan Control (60 mg / kg) 142.23 ± 7.11 251.32 ± 6.09 299.32 ± 6.12
Alloxan + CP (250 mg/kg) 52.32 ± 6.12** 200.31 ± 8.02** 214.36 ± 7.23**
Alloxan + CP (500 mg/kg) 57.31 ± 6.09** 210.26 ± 3.12** 220.71 ± 6.21**
Alloxan + Glibenclamide (600mg/kg) 61.32 ± 7.11** 203.26 ± 9.12** 209.73 ± 8.17**
** Significance P ≤ 0.01, compared to alloxan control group
Table 3  Effect of ethanol extract of Caesalpinia pulcherrima (CP) on blood glucose levels of alloxan - diabetic rats. 
[Values are mean ± SD of 6 animals]
Groups
Blood glucose levels (mg / 100ml)
Day 1 Day 4 Day 7 Day 10 Day 15
Normal Control  
(0.25% Tween 80)
88.0 ± 4.2 89.3 ± 3.9 85.3 ± 4.0 88.0 ±5 .1 86.0 ± 4.0
Alloxan Control  
(60 mg / kg)
298.0 ± 6.3 372.1 ± 2.6 412.3 ± 1.5 365.2 ± 1.8 363.2 ± 1.9
CP (250 mg/kg) 284. ± 6.1 210.2 ± 5.1** 170.2 ± 3.4** 132.2 ± 1.6** 120.1 ± 4.3**
CP (500 mg/kg) 216.3 ± 4.3 220.2 ± 3.9** 182.8 ± 4.2** 138.1 ± 2.3** 126.3 ± 2.1**
Glibenclamide  
(600mg/kg)
286.1 ± 2.3** 207.1 ± 2.1** 166.4 ± 2.1** 128.2 ± 4.3** 115.3 ± 4.1**
** Significance P ≤ 0.01, compared to alloxan control group
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Table 5  Effect of ethanol extract of Caesalpinia pulcherrima seed extract (CP) on rat serum cholesterol, total protein, 
triglycerides, creatinine and uric acid after alloxan administration. [Values are mean ± SD of 6 animals]
Groups
Cholesterol
(mg / dl)
Total Protein
(mg / dl)
Triglycerides 
(mg / 100 ml)
Creatinine
(mg / 100ml)
Uric acid 
(mg / 100ml)
Normal Control (0.25% Tween 80) 50.31±9.27 407.31±8.29 86.83±5.5 0.52±0.1 0.68±0.016
Alloxan control (60 mg / kg) 87.33±8.19 373.36±8.12 200.83±11.1 1.35±0.1 0.556±0.055
Alloxan + CP (250 mg/kg) 50.71±6.09** 398.31±6.21** 110.31±6.26** 0.59±0.10** 0.67±0.12**
Alloxan + CP (500 mg/kg) 53.32±7.13** 395.32±6.11** 117.61±3.15** 0.65±0.12** 0.63±0.017**
Alloxan + Glibenclamide
(600mg/kg)
45.71±8.11** 390.33±9.09** 108.00±6.1** 0.58±0.1** 0.63±0.006**
** Significance P ≤ 0.01, compared to alloxan control.
Table 6  Effect of ethanol extract of Caesalpinia pulcherrima seed extract (CP) on hepatic catalase, glycogen and 
protein levels. [Values are mean ± SD of 6 animals]
Groups
Catalase
( mg / g)
Glycogen
(mg / g)
Protein
(mg / g)
Normal Control (0.25%Tween- 80) 3.00 ± 0.10 50.00 ± 2.00 16.00 ± 1.20
Alloxan control (60 mg / kg) 0.88 ± 0.01 26.00 ± 1.50 8.60 ± 2.60
Alloxan + CP (250 mg/kg) 2.75 ± 0.02** 38.00 ± 3.60** 14.20 ± 1.30**
Alloxan + CP (500 mg/kg) 2.52 ± 0.004** 32.00 ± 3.60** 12.50 ± 1.20**
Alloxan + Glibenclamide (600mg/kg) 2.45 ± 0.05** 37.00 ± 4.00** 12.00 ± 1.20**
** Significance P ≤ 0.01, compared to alloxan control
Table 7  Effect of ethanol extract of Caesalpinia pulcherrima seed extract (CP) on FeCl2 - ascorbic acid (AA) - induced 
lipid peroxidation in rat liver homogenate in vitro. [Values are mean ± SD of 3 experiments]
Groups 
CP Concentration
(mg / ml)
MDA 
( n mole / g wet liver)
MDA 
Inhibition (%)
Normal Control - 1.34 ± 0.60 -
FeCl2 - AA control - 2.69 ± 0.02 -
FeCl2 – AA + CP 1.00 1.89 ± 0.02 49.60**
FeCl2 – AA + CP 5.00 1.63 ± 0.01 56.53**
FeCl2 - AA + CP 10.00 1.96 ± 0.02 47.73**
** Significance P ≤ 0.01,compared to FeCl2 - AA Control
Table 8  Effect of ethanol extract of Caesalpinia pulcherrima seed extract (CP) on DPPH radical scavenging activity 
[Values are mean of 3 experiments]
Conc (µg/ml) DPPH (% Inhibition)
25 42.75
50 63.75
100 62.75
200 70.00
400 75.37
800 73.77
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Toxicity studies
In the acute toxicity studies, CP was found to be 
nontoxic up to the highest dose used (1500 mg /kg), 
The LD50 of CP was therefore above 1500 mg /kg in 
mice (data not shown).
DISCUSSION
Diabetes Mellitus (DM) is a major public problem 
world wide.18 Many oral hypoglycemic agents are 
not very effective in lowering glucose in diabetic 
patients.19 Therefore, the search for effective drugs 
for the treatment of diabetes mellitus continues. 
Many herbs have been shown to have hypoglycemic 
action in animals and humans.20,21 There are several 
reports on the antidiabetic properties of Terminalia 
catappa, Momordica charantia22 elumbo nucifera23 
etc. The present study reports for the first time the 
anti - hyperglycemic and anti - diabetic effects of 
Caesalpinia pulcherrima in rats. CP exhibited anti - 
hyperglycemic effects in normal fasted and alloxan 
induced diabetic rats. The effect was comparable 
to glibenclamide, the positive control used in this 
study. Alloxan induces diabetes by destroying the 
b cells and the destruction is almost complete and 
it impairs renal function. In the present study, CP 
significantly reduced the blood glucose levels of 
alloxan diabetic rats indicating the mechanism of 
action may be due to potentiation of insulin release 
from the surviving pancreatic cells, but due possi-
bly to increased peripheral glucose utilization and 
inhibition of proximal tubular re absorption of 
glucose in the kidney.24
CP was also found to be an effective agent 
against other metabolic alterations induced as a 
consequence of diabetes. Insulin deficiency leads 
to various metabolic alterations in the animals like 
increased blood, cholesterol, triglycerides, AST, 
ALT, ALP and decreased levels of serum proteins.25 
In the present study, the levels of all the above 
parameters were almost normalized by CP treat-
ment this is due to an improvement in carbohydrate, 
fat and protein metabolism. The restoration of AST 
and ALP after treatment with CP also indicates a 
revival in insulin secretion. CP was able to increase 
the levels of catalase of diabetic rats, thereby help-
ing to detoxify the deleterious free radicals. It may 
prevent the formation of free radicals or it may 
scavenge the reactive oxygen metabolites through 
its antioxidant phytocompounds. In chronically 
diabetic animals, with high glucose levels, a 
decrease in liver glycogen could be attributed to the 
lesser availability of the enzyme glycogen synthase 
which in turn has been reported to be responsible 
Figure 1  Histological evidence of the protective effect of ethanol extract of 
seeds of Caesalpinia pulcherrima (CP) /glibenclamide on liver of 
alloxan induced diabetes in Wistar rats. (a). Normal control showing 
hepatocytes with well brought out nuclei and cytoplasm (x 300). 
(b). Liver of diabetic rat showing degenerated parenchymatous cells 
with severe necrosis and dilation of sinusoids (x 300). (c). Liver 
of diabetic rat after treatment with CP, showing hepatocytes with 
nearly normal appearance and minimal necrosis(x 300). (d). Liver 
of diabetic rat after treatment with glibenclamide showing normal 
hepatocytes (x 300)
Figure 2  Histological evidence of the protective effect of ethanol extract 
of seeds of Caesalpinia pulcherrima (CP) / glibenclamide on 
pancreas of alloxan induced diabetes in Wistar rats. (a). Normal 
control showing abundant patches of β - cells (x 300). (b). Pancreas 
of diabetic rat showing minimal pancreatic β - cells (x 300). 
(c). Pancreas of diabetic rat after treatment with CP seed extract 
showing pancreatic β - cells almost similar to that of control (x 300). 
(d). Pancreas of diabetic rat after treatment with glibenclamide, 
showing pancreatic β - cells similar to that of the control (x 300)
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for the incorporation of glucose moieties into the 
preexisting glycogen chain. In the present study, the 
normalization of depressed glycogen level by CP 
may be due to the regulation of glucose metabolism 
as reported by Dhawan et al26 with the herbal anti - 
diabetic formulation, D - 400.
Histopathological studies of pancreas, liver and 
kidney of control and CP treated diabetic rats, 
supported the results obtained from biochemical 
analysis CP treatment protected the pancreas which 
showed increased number of islets compared to 
alloxan diabetic control. Similarly the histopatho-
logical changes in the liver and kidneys were more 
or less normalized by CP treatment.
CONCLUSION
From the results, it is clear concluded that CP 
contained active phytocompounds capable of 
stimulating the surviving b cells of the pancreas 
damaged by alloxan, to release more insulin and 
perhaps the phytocompounds of CP were of an 
anti oxidant nature. Free radicals produced by 
alloxan are known to cause pancreatic damage. 
Phytochemical studies of C pulcherrima reported 
the presence of tannins and flavonoids27 which are 
known to have antidiabetic properties.28 CP also 
showed anti lipid peroxidation and free radical 
scavenging effects. Thus it acts as an antioxidant 
and protects the liver, kidneys and pancreas from 
free radical damage. Thus CP appears to be an 
attractive material for further studies, leading to 
possible drug development for diabetes.
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